Navigation Links
Valeant Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
Date:1/6/2012

MISSISSAUGA, Ontario, Jan. 6, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the 30th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2012 at 11:30 a.m. PT. The conference will be held at the Westin St. Francis in San Francisco, CA.

A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.

 

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

 


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Valeant Pharmaceuticals Completes Acquisition of iNova
2. Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance
3. Valeant Pharmaceuticals Completes Acquisition of Dermik
4. Valeant Announces Successful Results From Phase III Onychomycosis Trials
5. Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc.
6. Valeant Pharmaceuticals Receives Approval From FTC in Connection With Acquisition of Ortho Dermatologics and Dermik
7. Valeant Pharmaceuticals to Syndicate Incremental Term Loans
8. Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer
9. Valeant Announces Take-Up of Additional Afexa Shares and Special Meeting of Shareholders of Afexa to Approve Its Privatization
10. Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
11. Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Md. , Aug. 28, 2014 ... of novel anti-infective biologic and drug candidates targeting ... and FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced ... phase of cGMP manufacturing of SYN-004, Synthetic Biologics, ... Clostridium difficile ( C. difficile ) ...
(Date:8/28/2014)... 28, 2014 Today is the official launch ... higher education, student and pharmaceutical organizations that will work ... ADHD prescription stimulant medication. The Coalition will initially focus ... reported rates of nonmedical use vary, a 2013 study ... 1 of college students reported nonmedical use of ...
(Date:8/27/2014)... 27, 2014 TWi Pharmaceuticals, Inc. (4180.TT) today ... the United States Food and Drug Administration (FDA) ... megestrol acetate 125mg/ml oral suspension, the generic equivalent ... first-to-file and under Hatch Waxman rules, it will ...  TWi has completed the pre-launch preparation of the ...
Breaking Medicine Technology:Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 2Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 3Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 4Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 2New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 3New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 4New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 6TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2
... -- American Oriental Bioengineering, Inc. (NYSE: AOB ) ... (the "NYSE") has notified the Company that it is not ... to timely file its Annual Report on Form 10-K with ... rules, when a Company does not comply with annual report ...
...  In conjunction with its first quarter 2012 earnings release (expected to be ... CVD ) is pleased to invite you to listen to its ... on Thursday, May 3, 2012 at 9:00 a.m. ET. , ... and Slide Presentation , , , , When: , , , ...
Cached Medicine Technology:American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard 2
(Date:8/28/2014)... 28, 2014 Vitals, a recognized and trusted ... Fabi of Cosmetic Laser Dermatology one of their Top ... of patients to share their doctor experiences and rate their ... time, and follow-ups. The Vitals Top 10 Doctor recognition means ... was ranked one of the highest by patients. , “I’m ...
(Date:8/28/2014)... 2014 Altec Products, Inc., a ... announced today that they have been awarded the ... of the International Association of Microsoft Channel Partners ... founded in 1994, providing Microsoft Partners with a ... community at large while facilitating mutual growth and ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 The Baltimore ... web design firms in Baltimore and awarded The ... on 2013 revenue from Web design, The Canton Group ... The Canton Group’s clients include Fortune 1000, higher education, ... organizations. The Canton Group specializes in web design and ...
(Date:8/28/2014)... 28, 2014 Postcard-worthy views, star-laden skies, ... glamping by the beach in your own private bungalow ... Palmar at the Islands of Loreto. , The newest ... unforgettable experience in paradise with its romantic Honeymoon package, ... 2014. , “Villa del Palmar at the Islands of ...
(Date:8/28/2014)... Labor Day weekend typically conjures up images ... glorious glimpses of summer. However, more of Dr. ... their long weekend recovering from a quick cosmetic procedure. ... plastic and reconstructive surgeon based out of Newport Beach, ... their holiday weekends to do something for themselves. ...
Breaking Medicine News(10 mins):Health News:Dr. Sabrina Fabi of Cosmetic Laser Dermatology Recognized as Vitals Top 10 Doctor 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3Health News:The Canton Group is Recognized by the Baltimore Business Journal as the Largest Web Design Firm in Baltimore 2Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 2Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 3Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 4Health News:Newport Beach Facial Plastic Surgeon, Dr. Kevin Sadati Announces a Patient Trend of Scheduling Cosmetic Surgery Procedures over Long Holiday Weekends 2Health News:Newport Beach Facial Plastic Surgeon, Dr. Kevin Sadati Announces a Patient Trend of Scheduling Cosmetic Surgery Procedures over Long Holiday Weekends 3Health News:Newport Beach Facial Plastic Surgeon, Dr. Kevin Sadati Announces a Patient Trend of Scheduling Cosmetic Surgery Procedures over Long Holiday Weekends 4
... New research challenges the previously held belief that infants' ... new study finds the brain's left hemisphere plays the ... immediately after birth. ,Researchers are using functional ... activity in response to speech. They say this is ...
... try to avoid getting it, but researchers say common cold ... genetically engineer the common cold virus so that //it kills ... They did this by modifying one gene, so the virus ... the activity of another gene to ensure that the virus ...
... Government guidelines on the treatment of asthma have long ... for people with persistent forms of the condition.But reports ... people -- including parents of asthmatic children -- to ... growth retardation in children, weak bones in children and ...
... therapeutic option for patients with complicated type 1 diabetes, ... // Now, a new study finds ... worse survival than patients on the transplant waiting list ... Association supports a pancreatic transplant for patients who have ...
... a vaccine made from the common cold virus may induce ... the Centers for Disease Control and Prevention injected six monkeys ... parts of the SARS coronavirus. A new form of the ... were given a second vaccine 28 days later, and researchers ...
... women with diabetes have a higher risk of depression., ... 60 and 79. The participants were divided //into two ... the second included those without diabetes. Women who did ... groups, based on their levels of insulin resistance. ...
Cached Medicine News:Health News:New Technique to Study Infants Brain. 2Health News:Benefits and Risks of Asthma Treatment Questioned 2Health News:Pancreas Transplant for Diabetics 2
... GV is a sterile, non-pyrogenic, transparent ... noninflammatory, high molecular weight (average = ... hyaluronate. Healon GV contains 14 mg/mL ... a physiological sodium chloride-phosphate buffer (pH ...
... PROVISC ophthalmic viscosurgical device ... is characterized by high molecular ... surface tension. It provides excellent ... and is easily removed. It ...
... a product comes along that forever raises ... category. The new StealthStation TREON plus Treatment ... Built on the phenomenal success of the ... system in the worldthe new TREON plus ...
... the DigiCat Imager ("DCI") to provide rapid, ... The DCI can measure the cataract and ... objective, appropriate and timely surgical decision can ... technology is especially useful in todays healthcare ...
Medicine Products: